The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) ...

Investing.com - TD Cowen reiterated its Buy rating and $100.00 price target on DexCom (NASDAQ:DXCM) on Thursday, citing resolution of earlier issues with the company’s G7 continuous glucose monitoring ...

Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...

Shares of DexCom Inc. DXCM slid 1.80% to $66.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.34% to 6,711.20 and ...

Fintel reports that on September 29, 2025, Canaccord Genuity maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation. Analyst Price Forecast Suggests 57.07% Upside As of September 13, ...

With significant upside potential, DexCom, Inc. (NASDAQ:DXCM) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 25, 2025, given that previous ...

DexCom's devices are important to its customers' health. The company still has significant whitespace in its market. Despite potential obstacles, the stock is still attractive. Even so, the ...